Baltimore Reaches $80M Settlement with Teva, Secures $402.5M Over Opioid Crisis

Sep 10, 2024, 06:00 AM

The City of Baltimore has reached an $80 million settlement with Teva Pharmaceuticals over the company's role in the city's opioid crisis, officials announced Monday. This settlement is part of a larger effort, with Baltimore having secured a total of $402.5 million from drug companies related to the opioid crisis. Additionally, New York City plans to use $50 million in settlement funds to combat opioid addiction by supporting prevention programs.